IAXSX
Price
$9.50
Change
-$0.01 (-0.11%)
Updated
Sep 20 closing price
RRMGX
Price
$97.44
Change
-$0.69 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

IAXSX vs RRMGX

Header iconIAXSX vs RRMGX Comparison
Open Charts IAXSX vs RRMGXBanner chart's image
VY® T. Rowe Price Divers Mid Cap Gr S
Price$9.50
Change-$0.01 (-0.11%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$97.44
Change-$0.69 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IAXSX vs RRMGX Comparison Chart
Loading...
VS
IAXSX vs. RRMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IAXSX is a Buy and RRMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.4B vs. IAXSX (1.11B). IAXSX (0.00) and RRMGX (0.00) have matching dividends . IAXSX was incepted earlier than RRMGX: IAXSX (23 years) vs RRMGX (22 years). IAXSX is a more actively managed with annual turnover of: 45.00 vs. RRMGX (21.70). IAXSX has a lower initial minimum investment than RRMGX: IAXSX (0) vs RRMGX (2500). IAXSX (13.62) and RRMGX (13.62) have marching annual gain over last year. RRMGX return over 5 years is better than : 9.23 vs. IAXSX (-14.62).
IAXSXRRMGXIAXSX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years22 years-
Gain YTD0.8488.60510%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B31.4B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year13.6213.62100%
Returns for 3 years-30.79-16.28189%
Returns for 5 years-14.629.23-159%
Returns for 10 years-13.8233.74-41%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII26.020.16
+0.62%
Oceaneering International
COTY9.19-0.20
-2.13%
COTY
CLCO11.05-0.30
-2.64%
Cool Company Ltd
QLGN0.17-0.01
-3.55%
Qualigen Therapeutics
PRPH2.34-0.17
-6.77%
ProPhase Labs